(Taken from the application): Advances in technology have resulted in a dramatic change in the nature of genetic investigation. Innovation in computer and communications technology has made a wide variety of databases accessible to investigators via the Internet. The crucial role of bioinformatics in facilitating the utilization of this vast amount of information , which includes nucleotide and protein sequence data, genetic map data, genetic markers, and many other resources, is very clear. Refinement of high-throughput sequencing protocols has also changed the nature of genetic analysis. With these developments, the relative ease of obtaining sequence data has promoted a sequence-based characterization of the genome of a nature such that information is readily transferable from laboratory to laboratory. New techniques such as hybridization to DNA Achips@ promises to dramatically increase the rate one can pursue analysis of DNA sequence variation and differential gene expression. The requirement for bioinformatics and sequence capacity has, however, frequently put the genetic analysis that is most productive today beyond the reach of investigators with modest support The infrastructure is necessary to utilize this technology-intensive investigation requires a considerable investment in computers, instrumentation, and technical support. To address this, we have initiated a genome analysis effort to support investigations at the Brigham and Women's Hospital and its affiliated institutions at Harvard Medical School. This Core laboratory will be of considerable utility to investigators interested in understanding fundamental biology related to skin development, function, and pathology.
The Specific Aims of the Core are: 1. To provide support for state-of-the-art existing technologies of genomic analysis; including high-throughput sequencing, large-insert clone screening and analysis, cDNA screening and analysis, gene mapping, SAGE analysis, and bioinformatics. 2. To introduce novel technologies such as transcriptional profiling using hybridization to DNA chips.

Project Start
2002-04-01
Project End
2003-03-31
Budget Start
Budget End
Support Year
9
Fiscal Year
2002
Total Cost
$76,744
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Tian, Tian; Jin, Michelle Qiushuang; Dubin, Krista et al. (2017) IL-1R Type 1-Deficient Mice Demonstrate an Impaired Host Immune Response against Cutaneous Vaccinia Virus Infection. J Immunol 198:4341-4351
Pan, Youdong; Tian, Tian; Park, Chang Ook et al. (2017) Survival of tissue-resident memory T cells requires exogenous lipid uptake and metabolism. Nature 543:252-256
Volpicelli, Elgida R; Lezcano, Cecilia; Zhan, Qian et al. (2014) The multidrug-resistance transporter ABCB5 is expressed in human placenta. Int J Gynecol Pathol 33:45-51
Guenova, Emmanuella; Watanabe, Rei; Teague, Jessica E et al. (2013) TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma. Clin Cancer Res 19:3755-63
Majewska-Szczepanik, Monika; Paust, Silke; von Andrian, Ulrich H et al. (2013) Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-?, interferon-? and interleukin-12. Immunology 140:98-110
Zadran, Sohila; McMickle, Robert; Shackelford, David et al. (2013) Monitoring extra-vascular migratory metastasis (EVMM) of migrating cancer cells using an in vitro co-culture system. Protoc exch 2013:
Burkhardt, Ute E; Hainz, Ursula; Stevenson, Kristen et al. (2013) Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells. J Clin Invest 123:3756-65
Dowlatshahi, Mitra; Huang, Victor; Gehad, Ahmed E et al. (2013) Tumor-specific T cells in human Merkel cell carcinomas: a possible role for Tregs and T-cell exhaustion in reducing T-cell responses. J Invest Dermatol 133:1879-89
Seneschal, Julien; Clark, Rachael A; Gehad, Ahmed et al. (2012) Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36:873-84
Girouard, Sasha D; Laga, Alvaro C; Mihm, Martin C et al. (2012) SOX2 contributes to melanoma cell invasion. Lab Invest 92:362-70

Showing the most recent 10 out of 113 publications